Publications by authors named "Maria Cavallin"

Claim this Profile
B
Best practices in performing flow cytometry in a regulated environment: feedback from experience within the European Bioanalysis Forum.
Barry van der Strate, Robin Longdin, Marie Geerlings, Nora Bachmayer, Maria Cavallin

Bioanalysis· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-Human Pharmacokinetic and Pharmacodynamic Study of the Dual m-TORC 1/2 Inhibitor AZD2014.
Bristi Basu, Emma Dean, Martina Puglisi, Alastair Greystoke, Michael Ong, Maria Cavallin

Clin Cancer Res· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the pharmacodynamics and pharmacokinetics of the PARP inhibitor olaparib: a phase I multicentre trial in patients scheduled for elective breast cancer surgery.
Nigel Bundred, Janis Gardovskis, Janusz Jaskiewicz, Janis Eglitis, Viktor Paramonov, Maria Cavallin

Invest New Drugs· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I dose-finding, safety and tolerability study of AZD8330 in patients with advanced malignancies.
Roger B Cohen, Steinar Aamdal, Marta Nyakas, Maria Cavallin, Darron Green

Eur J Cancer· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis